Shasun Pharmaceuticals Ltd has decided to suspend the operations of production temporarily at its Cuddalore API facility after a fire accident, which claimed one employee's life.
The company today informed BSE the same, as directed by the government authorities.
"The Company is working with the Government authorities to resume operations at the earliest. The Company confirms that there will be no material impact on the revenue of the group during the current financial year," according to Shasun's announcement to BSE.